(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-(nonyloxy)tetrahydro-2H-pyran-3,4,5-triol, 95.0%, 1g

(4-(Butylsulfonyl)phenyl)boronic acid, 95.0%, 1g

(S)-(-)-1-(4-Methoxyphenyl)ethylamine>98.0%(GC)(T)5g

(2,4-Difluorophenyl)acetic acid ethyl ester, 98.0%, 25g

2-(Methylamino)benzaldehyde, 95.0%, 250mg

6-Azauracil, min. 98%, for biochemistry, 10 g, plastic packaging.

2-METHYL-N-((OXIRAN-2-YL)METHYL)PROPAN-2-AMINE, 95.0%, 1g

2-Bromo-4-fluorocinnamic acid, 98.0%, 5g

N-Boc-L-Cysteine, 95.0%, 10g

7-(2-Bromoethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, 97%, 250mg

(E)-2-CYANO-3-(4-HYDROXY-3,5-DIISOPROPYLPHENYL)ACRYLAMIDE, 95%, 5mg

5-Chloro-N-(4-(3-morpholino-2-oxo-5,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide, 95%, 1g

5-bromo-6-methoxy-4-methylpyridine-3-carbonitrile, 95.0%, 500mg